Updated Jul 16, 2026
CRANDELL KEITH has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $40K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | BOLD | Boundless Bio, Inc. | S — Open-market sale | 16.0K | $2.49 | $40K |
| 2026-07-06 | BOLD | Boundless Bio, Inc. | M — Option exercise | 16.0K | $1.03 | $16K |
| 2026-06-12 | MASS | 908 Devices Inc. | M — Option exercise | 14.1K | — | |
| 2026-02-09 | TWST | Twist Bioscience Corp | A — Grant or award | 5.1K | $0.00 | |
| 2025-06-11 | MASS | 908 Devices Inc. | M — Option exercise | 11.4K | — |
CRANDELL KEITH is a corporate insider — currently tracked as 10% Owner of Boundless Bio, Inc. (BOLD). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($40K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CRANDELL KEITH profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.